
Scaling Preclinical Imaging Through Quantitative Analysis
Raw imaging data rarely yields biological answers on its own. As drug development demands higher precision, researchers are turning to standardized quantitative workflows to translate preclinical signals into reliable endpoints for regulatory decision-making and human dose estimation.























